Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FMTBank is a specialized healthcare organization focused on providing high-quality fecal microbiota for transplantation (FMT) to clinical and research institutions. The company operates as a centralized bank that screens donors, processes samples, and distributes standardized FMT material for the treatment of recurrent Clostridioides difficile infections and other microbiome-related disorders. By implementing rigorous donor screening protocols and standardized manufacturing processes, FMTBank aims to improve the safety and accessibility of microbiome-based therapies. Their services support both routine clinical care and ongoing clinical trials investigating the role of the gut microbiome in various systemic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on fmtBank.